Fusion protein (extracellular domain of the activin receptor 2A and Fc of IgG1)
Red cell maturation agent for the treatment of anemia, and bone anabolic agent for the treatment of cancer-related bone loss
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor serine/threonine kinases (RSTK)
TGFBR2 family
ACVR2A
D09670 Sotatercept (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09670
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09670